These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Current disease-modifying therapies in multiple sclerosis. Kieseier BC; Hartung HP Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379 [TBL] [Abstract][Full Text] [Related]
5. Are clinical trials of therapeutic agents for MS long enough? Rudge P Lancet; 1999 Mar; 353(9158):1033-4. PubMed ID: 10199348 [No Abstract] [Full Text] [Related]
6. Are magnetic resonance findings predictive of clinical outcome in therapeutic trials in multiple sclerosis? The dilemma of interferon-beta. McDonald WI; Miller DH; Thompson AJ Ann Neurol; 1994 Jul; 36(1):14-8. PubMed ID: 8024255 [No Abstract] [Full Text] [Related]
7. Multiple sclerosis. Boggild M; Ford H Clin Evid; 2003 Jun; (9):1459-73. PubMed ID: 15366193 [No Abstract] [Full Text] [Related]
8. [Multiple sclerosis--recent advances in pathogenesis and treatment]. Itoyama Y; Fujihara K; Nakashima I; Misu T; Fujimori T; Sato S No To Shinkei; 2002 Jan; 54(1):5-21. PubMed ID: 11868352 [No Abstract] [Full Text] [Related]
9. How should we proceed with disease-modifying treatments for multiple sclerosis? Andersson PB; Waubant E; Goodkin DE Lancet; 1997 Mar; 349(9052):586-7. PubMed ID: 9057726 [No Abstract] [Full Text] [Related]
10. Non-specific immunosuppressants in the treatment of multiple sclerosis. Confavreux C; Vukusic S Clin Neurol Neurosurg; 2004 Jun; 106(3):263-9. PubMed ID: 15177781 [TBL] [Abstract][Full Text] [Related]
11. Natalizumab (Tysabri) returns. Med Lett Drugs Ther; 2006 Sep; 48(1243):76. PubMed ID: 16977289 [No Abstract] [Full Text] [Related]
12. New treatments and azathioprine in multiple sclerosis. Kolar OJ Lancet; 1997 Oct; 350(9083):1033. PubMed ID: 9329539 [No Abstract] [Full Text] [Related]
18. Interferon beta-1a and beta-1b for treatment of multiple sclerosis. Kappos L Lancet; 2002 Nov; 360(9343):1428; author reply 1428-9. PubMed ID: 12424020 [No Abstract] [Full Text] [Related]
19. [Alpha interferon in the treatment of multiple sclerosis. Update and experience in Cuba]. Cabrera-Gómez JA; López-Saura P Rev Neurol; 1999 May 1-15; 28(9):849-58. PubMed ID: 10390746 [TBL] [Abstract][Full Text] [Related]
20. Confounders in natural history of interferon-beta-treated relapsing multiple sclerosis. Gout O Ann Neurol; 2008 Jan; 63(1):126; author reply 126-7. PubMed ID: 17702028 [No Abstract] [Full Text] [Related] [Next] [New Search]